COVID-19: Up to 82% critically ill patients had low Vitamin C values
Tomasa-Irriguible TM, Bielsa-Berrocal L
Nutrition journal · 9. juuli 2021
AUTORITE KOKKUVÕTE
There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.
Algne kokkuvõte, esitatud muutmata kujul. © Autorid, levitatakse Creative Commonsi litsentsi CC BY alusel. Täpsed tingimused on märgitud allikas: algne artikkel.
Teaduslik teave; see ei asenda tervishoiutöötaja nõuannet. Uuringu olemasolu selles raamatukogus ei ole väide meie toodete kohta.
← Kõik uuringud